Expanding Access to Rare/Orphan Drugs and Biologics in Canada: A Business Development and Market Entry Project

Q&C is a pharmaceutical consultancy company which offers an array of services, some of which include providing guidance to ensure site compliance with the Good Manufacturing Principles (GMP), performing internal audits and helping drug companies navigate the Canadian regulatory landscape in all their operations. This project will aid Q&C in tapping into new markets and expanding their customer base by compiling a list of candidate pharmaceutical companies and regulatory firms operating in Europe that market rare drugs and/or biologics, and who may be interested in expanding their products to the Canadian market.

Faculty Supervisor:

Tony Harris

Student:

Partner:

Quality & Compliance Services

Discipline:

Life Sciences

Sector:

Professional, scientific and technical services

University:

University of Toronto

Program: